Digital Therapeutics Market is Expected to Witness the Fastest Growth in Asia-Pacific During the Forecast Period

Posted on 2019-07-30 by P&S Intelligence in Healthcare // 0 Comments

New York, United States, 2019-Jul-30 — /EPR Network/ —

The global digital therapeutics market is witnessing considerable growth due to increasing prevalence of chronic diseases and lifestyle associated diseases, growing geriatric population, need to control healthcare cost, and technological advancement. Moreover, increasing focus on preventive healthcare and increase in venture capital investment are supporting the growth of the market. The benefits of digital therapeutics such as improved drug adherence, ability to induce behavioral changes and patient convenience across the globe is also driving the growth of the market.

Download report sample at@ http://bit.ly/2zm470e

Geriatric population has weakened body functions, impaired blood circulation and are more susceptible to chronic diseases. As per the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing with high rate. In 2013, the global percentage of people aged 60 or above was 11.7% and it is expected to reach 21.1% by the end of 2050. Further, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050.

Digital therapeutics is health care interferences provided through a smart device to boost healthy behaviors and provide therapeutic effects. It is also known as software-as-a-drug. It is a digital system to treat medical conditions and it is cost effective and have the potential to improve patient engagement and bring substantial change in patient health. It is mainly prescribed to help and mange long term conditions such as insomnia, asthma and diabetes. It is used both in combination with conventional therapeutics and standalone.

Browse full report at@ http://bit.ly/2oUeDKe

Globally, the digital therapeutics market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing prevalence of chronic illness and growing geriatric population in the region.

The key players operating in the global digital therapeutics market are Proteus Digital Health Inc., Omada Health Inc., Welldoc Inc., Livongo Health, Noom Inc., Propeller Health, Canary Health Inc., and Mango Health Inc.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Matched content

Editor’s pick